The Comorbidity of Chronic Obstructive Pulmonary Disease and Peripheral Artery Disease – A Systematic Review

References

• Global Initiative for Chronic Obstructive Lung Disease Inc. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2018 report. 2018. Available from: http://www.goldcopd.org
   Google Scholar
• Januszek R, Mika P, Konik A, et al. The effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease. J Cardiol. 2014;64:145–151. doi:10.1016/j.jjcc.2013.12.002.
   PubMed Web of Science ®Google Scholar
• Aboyans V, Ricco J-B, Bartelink M-L, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816. doi:10.1093/eurheartj/ehx095.
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J.. 2016;37:2315–2381. doi:10.1093/eurheartj/ehw106.
   PubMed Web of Science ®Google Scholar
• Wozniak K, Sleszycka J, Safianowska A, et al. Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers. Arch Med Sci. 2012;8:477–483. doi:10.5114/aoms.2012.29525.
   PubMed Web of Science ®Google Scholar
• Wilke S, Watz H, Bals R, et al. Impact of peripheral artery disease on functional capacity and health status in patients with chronic obstructive pulmonary disease: results of the COSYCONET study. Am J Respir Crit Care Med. 2015;191:A6204.
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269, W64. doi:10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute, 2017. Available from: https://reviewersmanual.joannabriggs.org/
   Google Scholar
• Tschopp J, Dumont P, Hayoz D. True prevalence of COPD and its association with peripheral arterial disease in the internal medicine ward of a tertiary care hospital. Swiss Med Wkly. 2017;147:w14460. doi:10.4414/smw.2017.14460.
   PubMed Web of Science ®Google Scholar
• Sleszycka J, Wozniak K, Banaszek M, et al. Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease. Pol Merkur Lekarski. 2009;27:92–96.
   PubMedGoogle Scholar
• Castagna O, Boussuges A, Nussbaum E, et al. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil. 2008;15:270–277. doi:10.1097/HJR.0b013e3282f009a9.
   PubMedGoogle Scholar
• Pecci R, De La Fuente Aguado J, Sanjurjo Rivo AB, et al. Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Int Angiol. 2012;31:444–453.
   PubMed Web of Science ®Google Scholar
• Chen W, Lin M-S, Sun K-S, et al. Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1487–1492.
   PubMed Web of Science ®Google Scholar
• Pizarro C, Linnhoff F, van Essen F, et al. Lower extremity and carotid artery disease in COPD. ERJ Open Res. 2016;2:00037–02016. doi:10.1183/23120541.00037-2016.
   PubMedGoogle Scholar
• Houben-Wilke S, Jörres RA, Bals R, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and Systemic Consequences-Comorbidities Network Study. Am J Respir Crit Care Med. 2017;195:189–197. doi:10.1164/rccm.201602-0354OC.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Scelfo C, Tzani P, et al. Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation. Eur J Prev Cardiolog. 2017;24:990–999. doi:10.1177/2047487317695629.
   PubMed Web of Science ®Google Scholar
• Tuleta I, Farrag T, Busse L, et al. High prevalence of COPD in atherosclerosis patients. Int J Chron Obstruct Pulmon Dis. 2017;12:3047–3053. doi:10.2147/COPD.S141988.
   PubMed Web of Science ®Google Scholar
• Brusselle G, Bracke K, De Pauw M. Peripheral artery disease in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195:148–150. doi:10.1164/rccm.201608-1712ED.
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009;4:337–349.
   PubMedGoogle Scholar
• Śliwiński P, Górecka D, Jassem E, et al. [Polish respiratory society guidelines for chronic obstructive pulmonary disease]. Pneumonol Alergol Pol. 2014;82:227–263.
   PubMedGoogle Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968. doi:10.1183/09031936.05.00035205.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63:1046–1051. doi:10.1136/thx.2008.098483.
   PubMed Web of Science ®Google Scholar